retatrutide dosage trials Dosing Schedule: Proven 2026 Guide retatrutide dose study trial doses

PMID 8216285

Early trials show an average of 24% weight loss over 48 weeks higher than semaglutide or tirzepatide

Our clinic is dedicated to helping patients achieve sustainable, safe, and meaningful weight loss through a blend of modern medical therapies and holistic health strategies

Proper technique ensures consistent absorption and predictable pharmacokinetics, which is essential for staying on schedule with the dosing protocol

While these are different trials with different designs and not a direct head-to-head comparison, the data suggests retatrutide may deliver greater weight loss

How should GLP-3 RETA be stored